IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 144 filers reported holding IMMUNOMEDICS INC in Q2 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $854,000 | -74.2% | 41,000 | -78.1% | 0.05% | -74.6% |
| Q2 2018 | $3,306,000 | +103.8% | 187,500 | -12.4% | 0.20% | +89.4% |
| Q1 2018 | $1,622,000 | -63.8% | 214,000 | -22.7% | 0.10% | -63.1% |
| Q4 2017 | $4,476,000 | +15.6% | 277,000 | 0.0% | 0.28% | -6.0% |
| Q3 2017 | $3,872,000 | +58.3% | 277,000 | 0.0% | 0.30% | +50.8% |
| Q2 2017 | $2,446,000 | +20.0% | 277,000 | -12.1% | 0.20% | +17.8% |
| Q1 2017 | $2,038,000 | +76.3% | 315,000 | 0.0% | 0.17% | +57.9% |
| Q4 2016 | $1,156,000 | +12.9% | 315,000 | 0.0% | 0.11% | +13.8% |
| Q3 2016 | $1,024,000 | +40.1% | 315,000 | 0.0% | 0.09% | +8.0% |
| Q2 2016 | $731,000 | -7.2% | 315,000 | 0.0% | 0.09% | -20.9% |
| Q1 2016 | $788,000 | +44.1% | 315,000 | +164.7% | 0.11% | +25.0% |
| Q4 2013 | $547,000 | -62.3% | 119,000 | -49.1% | 0.09% | -68.1% |
| Q3 2013 | $1,451,000 | -42.6% | 234,000 | -49.7% | 0.28% | -40.0% |
| Q2 2013 | $2,530,000 | – | 465,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 4,373,178 | $371,851,000 | 55.73% |
| Avoro Capital Advisors LLC | 26,250,000 | $2,232,038,000 | 31.71% |
| Twin Securities, Inc. | 467,761 | $39,774,000 | 28.60% |
| Palo Alto Investors LP | 4,852,383 | $412,598,000 | 22.65% |
| Sand Grove Capital Management LLP | 470,000 | $39,964,000 | 21.19% |
| Beryl Capital Management LLC | 1,046,632 | $88,995,000 | 16.02% |
| Western Standard LLC | 158,065 | $13,440,000 | 15.26% |
| One68 Global Capital, LLC | 60,990 | $5,186,000 | 13.76% |
| First Light Asset Management, LLC | 1,577,880 | $134,167,000 | 13.75% |
| Boxer Capital, LLC | 4,500,000 | $382,635,000 | 13.22% |